Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 2693, March 15, 2007. doi: 10.1158/0008-5472.CAN-06-3654
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huveneers, S.
Right arrow Articles by Danen, E. H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huveneers, S.
Right arrow Articles by Danen, E. H.J.

Cell, Tumor, and Stem Cell Biology

Integrin {alpha}vß3 Controls Activity and Oncogenic Potential of Primed c-Src

Stephan Huveneers1,2, Iman van den Bout1, Petra Sonneveld1, Ana Sancho1, Arnoud Sonnenberg1 and Erik H.J. Danen1,2

1 Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands and 2 Division of Toxicology, Leiden Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands

Requests for reprints: Erik H.J. Danen, Division of Toxicology, Leiden Amsterdam Center for Drug Research, Leiden University, Einsteinweg 55, P.O. Box 9502, 2300 RA, Leiden, The Netherlands. Phone: 31-71-527-4486; E-mail: e.danen{at}lacdr.leidenuniv.nl.

Increased activity of the proto-oncogene c-Src and elevated levels of integrin {alpha}vß3 are found in melanomas and multiple carcinomas. Regulation of c-Src involves "priming" through disruption of intramolecular interactions followed by "activation" through phosphorylation in the kinase domain. Interactions with overexpressed receptor tyrosine kinases or mutations in the SRC gene can induce priming of c-Src in cancer. Here, we show that {alpha}vß3 promotes activation of primed c-Src, causing enhanced phosphorylation of established Src substrates, survival, proliferation, and tumor growth. The ß3 cytoplasmic tail is required and sufficient for integrin-mediated stimulation of all these events through a mechanism that is independent of ß3 tyrosine phosphorylation. Instead, experiments using Src variants containing the v-Src Src homology 3 (SH3) domain and using mutant ß3 subunits indicate that a functional interaction of the ß3 cytoplasmic tail with the c-Src SH3 domain is required. These findings delineate a novel integrin-controlled oncogenic signaling cascade and suggest that the interaction of {alpha}vß3 with c-Src may represent a novel target for therapeutic intervention. [Cancer Res 2007;67(6):2693–700]




This article has been cited by other articles:


Home page
RadiologyHome page
F. Kiessling, J. Huppert, C. Zhang, J. Jayapaul, S. Zwick, E. C. Woenne, M. M. Mueller, H. Zentgraf, M. Eisenhut, Y. Addadi, et al.
RGD-labeled USPIO Inhibits Adhesion and Endocytotic Activity of {alpha}v{beta}3-Integrin-expressing Glioma Cells and Only Accumulates in the Vascular Tumor Compartment
Radiology, November 1, 2009; 253(2): 462 - 469.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Lorger, J. S. Krueger, M. O'Neal, K. Staflin, and B. Felding-Habermann
Activation of tumor cell integrin {alpha}v{beta}3 controls angiogenesis and metastatic growth in the brain
PNAS, June 30, 2009; 106(26): 10666 - 10671.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H.-Y. Lin, M. Sun, H.-Y. Tang, C. Lin, M. K. Luidens, S. A. Mousa, S. Incerpi, G. L. Drusano, F. B. Davis, and P. J. Davis
L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C980 - C991.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Huveneers and E. H. J. Danen
Adhesion signaling - crosstalk between integrins, Src and Rho
J. Cell Sci., April 15, 2009; 122(8): 1059 - 1069.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. J. Ablooglu, J. Kang, B. G. Petrich, M. H. Ginsberg, and S. J. Shattil
Antithrombotic effects of targeting {alpha}IIb{beta}3 signaling in platelets
Blood, April 9, 2009; 113(15): 3585 - 3592.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Puigvert, S. Huveneers, L. Fredriksson, M. o. h. Veld, B. van de Water, and E. H. J. Danen
Cross-Talk between Integrins and Oncogenes Modulates Chemosensitivity
Mol. Pharmacol., April 1, 2009; 75(4): 947 - 955.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Huveneers, S. Arslan, B. van de Water, A. Sonnenberg, and E. H. J. Danen
Integrins Uncouple Src-induced Morphological and Oncogenic Transformation
J. Biol. Chem., May 9, 2008; 283(19): 13243 - 13251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.